Biotechnology Assets SA
MAD:BST

Watchlist Manager
Biotechnology Assets SA Logo
Biotechnology Assets SA
MAD:BST
Watchlist
Price: 0.29 EUR -0.68% Market Closed
Market Cap: 18.9m EUR
Have any thoughts about
Biotechnology Assets SA?
Write Note

Biotechnology Assets SA
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Biotechnology Assets SA
Net Income (Common) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Biotechnology Assets SA
MAD:BST
Net Income (Common)
-€3.1m
CAGR 3-Years
-58%
CAGR 5-Years
23%
CAGR 10-Years
N/A
Grifols SA
MAD:GRF
Net Income (Common)
€59.3m
CAGR 3-Years
-54%
CAGR 5-Years
-37%
CAGR 10-Years
N/A
Oryzon Genomics SA
MAD:ORY
Net Income (Common)
-€3.4m
CAGR 3-Years
0%
CAGR 5-Years
-23%
CAGR 10-Years
N/A
Pharma Mar SA
MAD:PHM
Net Income (Common)
€622k
CAGR 3-Years
-78%
CAGR 5-Years
N/A
CAGR 10-Years
-27%
No Stocks Found

Biotechnology Assets SA
Glance View

Market Cap
18.5m EUR
Industry
Biotechnology

Biotechnology Assets SA operates as a biopharmaceutical company. The company is headquartered in Jerez De La Frontera, Cadiz and currently employs 32 full-time employees. The company went IPO on 2011-06-14. The Firm’s main activities are: Research, development and production of biotechnological solutions aimed at improving the health and welfare of people and animals; Development, acquisition, transfer and exploitation of industrial and intellectual property rights; Distribution, marketing, export and import of the previously mentioned products. The Company, through its subsidiaries, is also present in Luxembourg, Hong Kong and USA.

BST Intrinsic Value
0.29 EUR
Overvaluation 1%
Intrinsic Value
Price

See Also

What is Biotechnology Assets SA's Net Income (Common)?
Net Income (Common)
-3.1m EUR

Based on the financial report for Jun 30, 2024, Biotechnology Assets SA's Net Income (Common) amounts to -3.1m EUR.

What is Biotechnology Assets SA's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
23%

The average annual Net Income (Common) growth rates for Biotechnology Assets SA have been -58% over the past three years , 23% over the past five years .

Back to Top